• LAST PRICE
    0.0000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 0.0000
  • Day Range
    ---
  • 52 Week Range
    Low 0.0000
    ---
    High 0.0000
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSCIE
SpectraScience Inc
4.8K
0.0x
---
United StatesMMTC
Micro Imaging Technology Inc
2.7K
0.0x
---
United StatesLFPI
LifePoint Inc
100.0
0.0x
---
United StatesNNMX
Nanomix Corp
4.9K
0.0x
---
United StatesXCRP
Xcorporeal Inc
20.0
0.0x
---
United StatesOWCP
OWC Pharmaceutical Research Corp
500.0
0.0x
---
As of 2024-05-02

Company Information

SpectraScience, Inc. is focused on developing its WavSTAT Optical Biopsy System (WavSTAT). The WavSTAT employs a risk technology that optically illuminates tissue in real-time to distinguish between normal and pre-cancerous or cancerous tissue. The Company has developed a technology platform to determine if tissue is normal, pre-cancerous or cancerous, without the need for a physical biopsy. The WavSTAT4 Optical Biopsy System operates by using cool, safe ultraviolet (UV) laser light to optically illuminate and analyze tissue, enabling the physician to make a diagnosis during endoscopy when screening for cancer and, if warranted, to begin immediate treatment during the same procedure. The WavSTAT4 uses laser-induced auto-fluorescence to obtain spectral information from tissue at the suspected site. The system is classified as a non-significant risk device, which transmits low-level UV laser light energy through an optical fiber to the tissue through the working channel of an endoscope.

Contact Information

Headquarters
11568 Sorrento Valley Road, Suite 11SAN DIEGO, CA, United States 92121
Phone
858-847-0200
Fax
858-847-0880

Executives

Independent Chairman of the Board
Mark McWilliams
President, Chief Executive Officer, Chief Financial Officer, Director
Michael Oliver
Chief Financial Officer, Secretary
Lowell Giffhorn
Independent Director
Sheldon Miller
Independent Director
Rand Mulford

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$4.8K
Revenue (TTM)
$0.00
Shares Outstanding
4.8B
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$0.00
Book Value
$-0.01
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.